Table 1.
Concurrent pathology |
|||||
---|---|---|---|---|---|
Pathology on biopsy | Banff arterial inflammation >v0 | Presence of alloantibodies | TG> cg1 | Positive C4d PTC | Banff acute> suspicious |
TG> cg1 | 0.600 | <0.001 | <0.001 | 0.012 | |
Fibrosis ≥50% | 0.820 | 0.001 | <0.001 | <0.001 | 0.77 |
Banff acute > suspicious | <0.001 | 0.110 | 0.100 | 0.060 | |
Banff arterial inflammation >v0 | 0.970 | 0.910 | 0.990 | <0.001 | |
Positive C4d PTC | 0.150 | <0.001 | <0.001 | 0.15 | |
Presence of alloantibodies | 0.970 | <0.001 | <0.001 | 0.22 | |
Banff infiltrate >i1 | 0.230 | 0.280 | 0.380 | 0.670 | <0.001 |
Banff glomerular inflammation >g1 | 0.001 | 0.001 | <0.001 | 0.001 | 0.002 |
N > 150 |
Later pathology |
|||||
---|---|---|---|---|---|
Pathology on biopsy | Banff acute > suspicious | Positive C4d PTC | Chronic arteriopathy | TG > cg1 | Fibrosis ≥50% |
TG > cg1 | >0.05 | <0.001 | <0.001 | <0.001 | |
Fibrosis ≥50% | >0.05 | 0.050 | 0.150 | 0.040 | |
Banff acute > suspicious | 0.110 | 0.630 | 0.120 | 0.67 | |
Banff arterial inflammation >v0 | <0.001 | 0.600 | <0.001 | 0.730 | 0.74 |
Positive C4d PTC | >0.05 | <0.001 | <0.001 | <0.001 | |
Presence of alloantibodies | 0.150 | <0.001 | <0.001 | <0.001 | <0.001 |
Banff infiltrate >i1 | < 0.001 | 0.720 | 0.680 | 0.360 | 0.36 |
Banff glomerular inflammation >g1 | >0.05 | <0.001 | <0.001 | <0.001 | 0.001 |
N > 150; for CAA (autopsies) >47 |